1.Metabolic syndrome and plasma biomarkers in ischemic heart disease
Anudari I ; Badamkhand M ; Buyandelger J ; Myankhai B ; Gansukh T ; Sodgerel B ; Chimeglkham B
Mongolian Medical Sciences 2026;215(1):159-169
Ischemic heart disease (IHD) remains a leading cause of morbidity and mortality worldwide.
Metabolic syndrome (MetS), a cluster of interrelated metabolic abnormalities including central
obesity, insulin resistance, hypertension, dyslipidemia, and impaired glucose metabolism, has
emerged as a major contributor to the development and progression of IHD. The presence
of MetS significantly increases cardiovascular risk and worsens clinical outcomes in patients
with established coronary artery disease.
We summarize current evidence on the role of metabolic syndrome in ischemic heart disease,
with a focus on underlying pathophysiological mechanisms and clinical implications. Key
mechanisms linking MetS to IHD include insulin resistance, endothelial dysfunction, chronic
low-grade inflammation, oxidative stress, atherogenic dyslipidemia, and pro-thrombotic
states, all of which promote atherosclerosis and plaque instability. In addition, emerging
biomarkers such as high-sensitivity C-reactive protein (hs-CRP), lipoprotein-associated
phospholipase A₂ (Lp-PLA₂), adipokines, and inflammatory cytokines provide further insight
into the complex interaction between metabolic disturbances and ischemic heart disease.
Understanding the role of metabolic syndrome in IHD is essential for early risk stratification
and targeted prevention strategies. Comprehensive management of metabolic syndrome
components may reduce the incidence, severity, and recurrence of ischemic heart disease.
This review highlights the importance of an integrated metabolic and cardiovascular approach
in the prevention and management of IHD.
2.Effect of Traditional Medicine and Acupuncture Therapy on Postoperative Ileus Following Adhesive Small Bowel Obstruction
Undarmaa B ; Nasanhishig D ; Oyun-Erdene U ; Tserendulam G ; Anudari M ; Alzakhgui M ; Oyunbileg Yu ; Batchimeg N ; Enkhtuya V
Mongolian Journal of Health Sciences 2026;93(3):221-226
Background:
Adhesion small bowel obstruction (ASBO) is a common complication following abdominal surgery and can significantly impair postoperative recovery. This condition necessitates the exploration of more effective therapeutic approaches.
Aim:
The aim of this study was to evaluate the clinical efficacy of Traditional Mongolian Medicine (TMM) combined with acupuncture in the management of postoperative ileus secondary to adhesion-related small bowel obstruction.
Case Presentation:
We report the case of a 47-year-old female patient who developed postoperative ileus. The therapeutic intervention consisted of a combined regimen of traditional herbal pharmacotherapy and electroacupuncture. The clinical outcomes were assessed based on the resolution of symptoms and the restoration of gastrointestinal function.
Result:
Following the administration of the integrated treatment, the patient exhibited a marked reduction in abdominal pain. Objective clinical improvement was noted through the successful restoration of intestinal peristalsis and the normalization of flatus and defecation.
Conclusion
The findings of this case study suggest that Traditional Mongolian Medicine, particularly when integrated with electroacupuncture, may be an effective and viable modality for promoting the recovery of gastrointestinal motility in patients with adhesion-related small bowel obstruction.
Result Analysis
Print
Save
E-mail